Literature DB >> 23392800

Effects of xenogeneic adipose-derived stem cell transplantation on acute-on-chronic liver failure.

Wei Zhu1, Xiao-Lei Shi, Jiang-Qiang Xiao, Guang-Xiang Gu, Yi-Tao Ding, Zheng-Liang Ma.   

Abstract

BACKGROUND: Adipose-derived stem cells (ADSCs) are particularly attractive in future clinical applications of stem cell-based therapy for acute-on-chronic liver failure (ACLF). This study was undertaken to evaluate the therapeutic potential of ADSCs on ACLF.
METHODS: ADSCs isolated from porcine fat tissue were expanded and labeled with BrdU. Rabbit models of ACLF were created by administration of D-Gal following CCl4-induced cirrhosis. One day after administration of D-Gal, rabbits of the ACLF/ADSCs group (n=15) were received ADSCs transplantation, while those in the ACLF/saline group (n=15) were treated with the same volume of saline. Biochemical parameters and histomorphological scoring were evaluated; the distribution and characteristics of transplanted ADSCs as well as the pathology of the liver were examined.
RESULTS: ADSCs transplantation improved the survival rate and the liver function of rabbits with ACLF. Biochemical parameters of the ACLF/ADSCs group were improved compared with those of the ACLF/saline group, and histomorphological scoring of the ACLF/ADSCs group was significantly lower than that of the ACLF/saline group. ADSCs were identified in the periportal region of the liver after cell transplantation.
CONCLUSION: Xenogenic ADSCs have therapeutic efficacy in the ACLF rabbit model.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392800     DOI: 10.1016/s1499-3872(13)60007-7

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  8 in total

1.  Adipose-tissue derived porcine mesenchymal stem cells efficiently ameliorate CCl4-induced acute liver failure in mice.

Authors:  Shourong Liu; Ruihong Guo; Xiaoli Hou; Yue Zhang; Xiawei Jiang; Tiantian Wang; Xiaoyu Wu; Keyang Xu; Xiaoping Pan; Liang Qiao
Journal:  Cytotechnology       Date:  2020-04-25       Impact factor: 2.058

2.  Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells Ameliorate Acute Hepatic Injury in Dogs.

Authors:  Takahiro Teshima; Hirotaka Matsumoto; Masaki Michishita; Akito Matsuoka; Maika Shiba; Tomokazu Nagashima; Hidekazu Koyama
Journal:  Stem Cells Int       Date:  2017-12-28       Impact factor: 5.443

Review 3.  Research Advancements in Porcine Derived Mesenchymal Stem Cells.

Authors:  Dinesh Bharti; Sharath Belame Shivakumar; Raghavendra Baregundi Subbarao; Gyu-Jin Rho
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

4.  Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury.

Authors:  Liuhua Zhou; Qun Song; Jiangwei Shen; Luwei Xu; Zheng Xu; Ran Wu; Yuzheng Ge; Jiageng Zhu; Jianping Wu; Quanliang Dou; Ruipeng Jia
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

Review 5.  End-stage liver failure: filling the treatment gap at the intensive care unit.

Authors:  Robert A F M Chamuleau; Ruurdtje Hoekstra
Journal:  J Artif Organs       Date:  2019-09-18       Impact factor: 1.731

Review 6.  Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition?

Authors:  Jaciara Fernanda Gomes Gama; Liana Monteiro da Fonseca Cardoso; Jussara Machado Lagrota-Candido; Luiz Anastacio Alves
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

Review 7.  Xenogeneic stem cell transplantation: Research progress and clinical prospects.

Authors:  Lin-Li Jiang; Hui Li; Lei Liu
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

Review 8.  Still 'dwelling in the possibility' - critical update on stem cell therapy for acute on chronic liver failure.

Authors:  Cyriac Abby Philips; Philip Augustine
Journal:  World J Stem Cells       Date:  2020-10-26       Impact factor: 5.326

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.